Join our newsletter
Get updated info, tips and news about breastfeeding, e-lactancia project and other initiatives from APILAM
Legitimation: Consent of the interested party
As a user and interested I inform you that the data you provide will be located on the servers of MailChimp (email marketing provider of APILAM) outside the EU in the USA. MailChimp is covered by the EU-US Privacy Shield agreement, whose information is available here, approved by the European Committee for Data Protection. See Mailchimp's privacy policy. (https://mailchimp.com/legal/privacy/).
The fact that you do not enter the personal data that appear on the form as mandatory may have the consequence that we can not meet your request.
You can exercise your rights of access, rectification, limitation and delete the data in apilam.es@gmail.com as well as the right to file a claim with a control authority.
You can consult the additional and detailed information on Data Protection on this website: http://e-lactancia.org, as well as consult our own privacy policy.
A product which is used topically without there being any scientific proof of its effectiveness. It has hardly any bibliographical references in medical literature and a single published study indicates its very low effectiveness in hair regrowth (Orasan 2016).
Since the last update, we have not found published data on its excretion in breast milk.
The small dose used and very low plasma absorption of most topical dermatological preparations make it unlikely that a significant amount will transfer into breast milk.
It is normal to lose hair in the months following pregnancy and this has nothing to do with breastfeeding but with the end of the resting phase in hair loss that occurs during pregnancy. Within 12 months of giving birth, the hair grows back without causing alopecia.